Cellular Necrosis and Acute Pancreatitis

Wei Huang,Robert Sutton,Kiran Altaf,Frank W. Wright
2012-01-01
Abstract:Sustained elevations of cytosolic Ca2+ induce pancreatic acinar cell (PAC) death. Caffeine inhibits Ca2+ elevations and necrosis in vitro, and ameliorates AP in vivo, potentially via inhibition of the inositol 1,4,5 -trisphosphate receptor (IP3R). We aimed to compare inhibition of Background: Post-ERCP acute pancreatitis (post-ERCP-AP) occurs in w5% of patients undergoing ERCP, severe in w1%. Despite multiple trials, optimal prophylaxis remains undetermined. We sought to clarify the effectiveness of prophylactic interventions for post-ERCP AP through multiple meta-analyses of randomised clinical trials (RCTs). Methods: MEDLINE, EMBASE and the Cochrane Library were searched by two independent reviewers to identifyall RCTs that tested treatments to reduce post-ERCP AP. Data were extracted to permit Jadad scoring, grouping of RCTs by therapeutic mechanism and separate meta-analysis of each group. The main outcome measure was post-ERCP AP; defined as amylase elevated to >3x upper limit of normal with >24 h abdominal pain. Results: 49 high quality RCTs (Jadad 3) were identified. Pancreatic stents (trials (T)- 3;patients(P)-294;RR-0.21;95%CI0.09-0.50) were most effective; significant reductions in post-ERCP AP resulted from non- steroidal anti-inflammatory drugs (NSAIDs;T-8;P-1901;RR-0.59;CI-0.38- 0.92), secretion inhibitors (T-12;P-4178;RR-0.61;CI-0.43-0.88), protease inhibitors (T-6; P-3296;RR-0.59;CI-0.38-0.93) and smooth muscle relax- ants (T-6;P-1903;RR-0.68;CI-0.48-0.97). Anti-oxidants (T-5;P-2100;RR- 0.90;CI-0.54-1.50), anti-coagulants (T-2;P-553;RR-0.94;CI-0.54-1.65), non-ionic (vs ionic) contrast agents (T-3;P-2155;RR-1.12;CI-0.86-1.46) and steroids (T-4;P-2039;RR-1.18;CI-0.93-1.50) did not reduce post-ERCP AP. Conclusion: Pancreatic stents, NSAIDs, protease and secretion inhibi- tors and smooth muscle relaxants reduce the risk of post-ERCP AP. Large well-designed RCTs of combination versus single agent prophylaxis are required. Abstract: Obesity is a well-established risk factor for acute pancreatitis. Increased visceral fat adiposity has been shown to exacerbate the pro- inflammatory milieu experienced by patients. This study aimed to inves- tigate the relationship between severity of acute pancreatitis and indi- vidual fat volumes measured on Computed Tomography (CT) scan.
What problem does this paper attempt to address?